Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.

摘要: Background: Hepatocellular carcinoma (HCC) is highly prevalent in Hong Kong due to the high prevalence of chronic hepatitis B infection. Liver cancer fourth most common and third cause death. Due case load, there a level local expertise treating HCC, full spectrum treatment modalities available. This document summarizes how these should be used based on latest evidence. Summary: In 2 meetings held early 2017, multidisciplinary group clinicians, including liver surgeons, interventional radiologists, clinical oncologists, medical met update consensus statements for management HCC. These are evidence give detailed guidance deploy modalities, particular cases HCC which not suited surgical resection. Key Messages: information decide if patient candidate resection, methods improve candidacy use various nonsurgical interventions manage patients ineligible